Dr. Jilani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3285 Skypark Dr
Torrance, CA 90505Phone+1 310-750-3300Fax+1 310-379-3567- Is this information wrong?
Clinical Expertise
- Medical oncology, Hematology, Hematologic oncology
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1995 - 1998
University of Missouri-ColumbiaResidency, Internal Medicine, 1993 - 1995- University of Missouri-ColumbiaInternship, Internal Medicine, 1992 - 1993
Aga Khan Medical CollegeClass of 1984, Bachelor of Medicine and Surgery (M.B.B.S.)
Certifications & Licensure
CA State Medical License 1995 - 2024- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients Start of enrollment: 2009 Oct 01
- A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC Start of enrollment: 2013 Apr 01
- A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label Start of enrollment: 2014 Nov 01
Publications & Presentations
PubMed
- 1 citationsThe spectrum of neurological complications in Pakistani patients with malignancies.Asif Sharfuddin, Hala Fatima, Syed M Jilani, Farah H. Mozaffar, Tahseen Mozaffar> ;JPMA. the Journal of the Pakistan Medical Association. 2008 Apr 1
- The clinical pattern of HER-2/neu oncogene overexpressing breast cancer in Pakistani patients at initial presentation: an analysis of HER-2/neu positive versus negativ...Siddiqui, T., Khan, S., Kayani, N., Salam, A., Kiran, S., Jilani, S. M.> ;J Pak Med Assoc. 1999 Dec
- Treatment failure of tuberculosis due to concomitant pathology.Qasim, Z. A., Sarwari, A. R., Jilani, S. M.> ;J Pak Med Assoc. 2003 Aug
Press Mentions
How I Found (And Trusted) My Doctor for Skin Cancer as a Person of ColorMay 23rd, 2023- Safety and Efficacy of Telatinib in Combination with Keytruda in Subjects with Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular CarcinomaMarch 15th, 2021
Professional Memberships
- Member
- Member
- Los Angeles County Medical AssociationMember
- Medical Oncology Association of Southern CaliforniaMember
- Southern California Academy of Clinical OncologyMember
External Links
- Science 37, Inc.http://www.science37.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
